Ferguson Shapiro’s Bristol-Myers Squibb BMY Stock Holding History

Ferguson Shapiro’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$325K	Buy	5,638 +9	+0.2%	+$517	0.1%	65
2026 Q1	$341K	Buy	5,629 +10	+0.2%	+$583	0.1%	56
2025 Q4	$303K	Buy	5,619 +11	+0.2%	+$529	0.09%	60
2025 Q3	$253K	Sell	5,608 -279	-5%	-$13K	0.08%	58
2025 Q2	$273K	Sell	5,887 -106	-2%	-$5.2K	0.09%	55
2025 Q1	$365K	Buy	5,993 +9	+0.2%	+$525	0.14%	49
2024 Q4	$338K	Buy	5,984 +104	+2%	+$5.81K	0.13%	50
2024 Q3	$304K	Buy	5,880 +807	+16%	+$37.9K	0.11%	48
2024 Q2	$211K	Hold	5,073	–	–	0.08%	59
2024 Q1	$275K	Buy	+5,073	New	+$258K	0.13%	35

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Ferguson Shapiro's BMY Position: Q2 2026 in Review

Ferguson Shapiro increased its Bristol-Myers Squibb (BMY) stake by 0.16% in Q2 2026, buying an estimated $517 and bringing the position to 5,638 shares worth $325K. The position accounts for 0.1% of the portfolio, ranked #65.

Ferguson Shapiro first reported a position in BMY in Q1 2024 and has held it in 10 quarters since. The position peaked at $365K in Q1 2025. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Ferguson Shapiro held 5,638 shares of Bristol-Myers Squibb worth $325K as of Q2 2026.
Ferguson Shapiro bought 9 Bristol-Myers Squibb shares in Q2 2026, an estimated $517.
Bristol-Myers Squibb made up 0.1% of Ferguson Shapiro's portfolio in Q2 2026, its #65 holding.
Ferguson Shapiro first reported a position in Bristol-Myers Squibb in Q1 2024 and has held it in 10 quarters since.
Ferguson Shapiro's Bristol-Myers Squibb position peaked at $365K in Q1 2025.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Ferguson Shapiro's 13F filing for Q2 2026, filed 9 Jul 2026.